Curia France Sas
France Updated 9 July 2026
The public registers hold a second record for Curia France Sas. The fuller profile,
with 116 active US DMFs and 8 valid CEPs, is at Curia.
Figures on this page cover only this record.
Curia France Sas is an API manufacturer based in France. It holds 2 active US drug master files. Its most recent recorded inspection, by US FDA, closed on 3 March 2022 as VAI.
2
registered plants
2 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 3 March 2022 VAI US FDA
- 8 October 2021 VAI US FDA
- 17 January 2019 VAI US FDA
- 18 November 2014 NAI US FDA
- 13 November 2014 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| France, France | 3006257961 |
| France, France | 3009615607 |
What they file, and where
Also appears on these molecule pages
Comparing suppliers?
Choose your molecules and target markets. Curia France Sas comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 3 March 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability